▲ 34 r/sellasLifescience
Live Discussion - SLS STIFEL - Targeted Oncology Investor Conference 2PM Eastern Standard. May 19th
- Don't forget to register in advance.
- Expecting to Hear CEO discuss / Buyout Related Topics
u/Run4theRoses2 — 2 days ago
u/Run4theRoses2
▲ 4 r/StockLaunchers
Immunotherapy for AML Remission Maintenance - GPs Phase 3 Results $SLS Now Truly Imminent. 80th Event PR offers as sure a Sure thing there ever was or Will Be in the Market
SLS Announced the 60th Event, the share price Launched
( IDMC Unblinded actual MOS and IR Data from the Interim Analysis - told all industry participants Gps works. )
SLS Announced the 72nd Event, the share price Launched
SLS Announced the 78th Event, the share price Launched
SLS is about to announce the 80th and Final Event ... Not the trial results, just the 80th event, the share Price will launch ahead of the Phase 3 Result, which is about 40x more valuable than the current share price.
The 80th Event Puts a $28B TAM - $40B of Value on the Table.
- Ballistic Verticality incoming.
THE 80th EVENT PR is a A SURE THING WINNER - massive Catalyst to be Followed by an even more massive catalyst-Final Results Giving Gps the FDA Green Light to Generate Tens of Billions of Dollars
- Tens of Billions in Real Revenue worth $40B to $LLY $ABBV
- this $1.2B Manipulated Equity is worth $40B the Instant P3 Data Hits
Immunotherapy for AML Remission Maintenance - GPs Phase 3 Results $SLS Now Truly Imminent. 80th Event PR offers as sure a Sure thing there ever was or Will Be in the Market
u/Run4theRoses2 — 4 days ago
▲ 0 r/Biotechplays
Immunotherapy for AML Remission Maintenance - GPs Phase 3 Results $SLS Now Truly Imminent. 80th Event PR offers as sure a Sure thing there ever was or Will Be in the Market
Anyone INVESTING NOW ahead of the 80th EVENT is Locked into a 99.999% win.
SLS Announced the 60th Event, the share price Launched
( IDMC Unblinded actual MOS and IR Data from the Interim Analysis - told all industry participants Gps works. )
SLS Announced the 72nd Event, the share price Launched
SLS Announced the 78th Event, the share price Launched
SLS is about to announce the 80th and Final Event ... Not the trial results, just the 80th event, the share Price will launch ahead of the Phase 3 Result, which is about 40x more valuable than the current share price.
The 80th Event Puts a $28B TAM - $40B of Value on the Table.
- Ballistic Verticality incoming.
THE 80th EVENT PR is a A SURE THING WINNER - massive Catalyst to be Followed by an even more massive catalyst-Final Results Giving Gps the FDA Green Light to Generate Tens of Billions of Dollars
- Tens of Billions in Real Revenue worth $40B to $LLY $ABBV
- this $1.2B Manipulated Equity is worth $40B the Instant P3 Data Hits
Immunotherapy for AML Remission Maintenance - GPs Phase 3 Results $SLS Now Truly Imminent. 80th Event PR offers as sure a Sure thing there ever was or Will Be in the Market
u/Run4theRoses2 — 4 days ago
▲ 6 r/biotech_stocks
" There is No Such Thing as a Sure thing in BIO " --- how many inch, thick mile wide Retail Lemmings, really believe this Horse Manure? AML CR2/3 rNPV
" There is No Such Thing as a Sure thing in BIO " --- how many inch, thick mile wide Retail Lemmings, really believe this Horse Manure?
Most.... ....
Gps Phase 3 Results offering the Investment of a Lifetime and the Preceding 80th EVENT Announcement WILL Launch the SLS SHARE PRICE ...@ME
GPs Phase 3 Results are Coming, they are Inevitable, and Just before the Topline Data is released, and the Ballistic Verticality ensues, SLS will announce the 80th Event needed for the Final Analysis.
The 80th EVENT PR Announcement is Offering as SURE a THING there'll ever be
•
SLS Announced the 60th Event, the share price Launched
SLS Announced the 72 Event, the share price Launched
SLS is about to announce the 80th and Final Event ... Not the results just the 80th event, the share Price will launch ahead of the Phase 3 Result, which is about 40x more valuable than the current share price.
The 80th Event Puts a $40B Mountain in view.
- Ballistic Verticality incoming.
if you want to identify the truth, good luck and focus on actual data / facts.
26 months after enrollment completed, 49 / 50 patients remain alive.
AML post secondary salvage, in a setting where the largest US REGAL clinician is on record saying 'you will not see survival past 12 months'.
- 3 Dr's Treating actual Patients are on record stating MOS for patients onBAT is 'dismal, not durable', 'extremely poor - 5-7 months'.
MOS and IR data from the actual Interim Analysis - was UNBLINDED.
Industry Players accumulating Know.
Most of the 49 or 50 REGAL Phase 3 Patients, who remain continue receive GPS Immunotherapy.
- after being asked precisely
- how long do control patients survive in his clinical practice experience using BAT.
" Median OS is just 7 months, 6-8 months. " for patients Using Aza + VEN
Aza+VEN BAT for Control recently Failed Large Phase 3 Trials conducted by $ABBV, including 2 Ph3 Fails for AML Remission Maintenance.
VIALE-M FAILED VIALE-T FAILED -VERONA Failed
GPS Phase 2 MSKCC AML Remission Maintenance in CR1 MOS was Better than transplant - NYR >67.6 months
GPS Phase 2 AML CR2 Second Remission Maintenance. Statistical Significant p. val .02 - MOS was 21 months vs < 6 months
u/Run4theRoses2 — 7 days ago
$SLS Stock Twits #1 Trending - Phase 3 Registrational Results Officially Any Day Now Watch Mode --- Phase 3 results for an Acute Myeloid Leukemia remission Maintenance Immunotherapy. TAM $28B
REGAL Phase 3 Trial ongoing 5+ years, now at the finish line.
49 patients remain 🙏 of 128 patients enrolled at Least 26 months ago ranging up to 64 months.
80th EVENT Will Be Announced Followed by the Top Line Results which are 40X more Valuable than Current Manipulated / Share Price.
https://www.reddit.com/r/sellasLifescience/comments/1td6xjq/sls_free_money_anyone_investing_now_ahead_of_the/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button
SLS Announced the 60th Event, the share price Launched
SLS Announced the 72nd Event, the share price Launched
SLS Announced the 78th Event, the share price Launched
SLS is about to announce the 80th and Final Event ... Not the results just the 80th event, the share Price will launch ahead of the Phase 3 Result, which is about 40x more valuable than the current share price.
The 80th Event Puts a $40B Mountain in view.
- Ballistic Verticality incoming.
if you want to identify the truth, good luck and focus on actual data / facts.
26 months after enrollment completed, 49 / 50 patients remain alive.
AML post secondary salvage, in a setting where the largest US REGAL clinician is on record saying 'you will not see survival past 12 months'.
- 3 Dr's Treating actual Patients are on record stating MOS for patients onBAT is 'dismal, not durable', 'extremely poor - 5-7 months'.
MOS and IR data from the actual Interim Analysis - was UNBLINDED.
Industry Players accumulating Know.
Most of the 49 or 50 REGAL Phase 3 Patients, who remain continue receive GPS Immunotherapy.
- after being asked precisely
- how long do control patients survive in his clinical practice experience using BAT.
" Median OS is just 7 months, 6-8 months. " for patients Using Aza + VEN
Aza+VEN BAT for Control recently Failed Large Phase 3 Trials conducted by $ABBV, including 2 Ph3 Fails for AML Remission Maintenance.
VIALE-M FAILED VIALE-T FAILED -VERONA Failed
GPS Phase 2 MSKCC AML Remission Maintenance in CR1 MOS was Better than transplant - NYR >67.6 months
GPS Phase 2 AML CR2 Second Remission Maintenance. Statistical Significant p. val .02 - MOS was 21 months vs < 6 months
u/Run4theRoses2 — 7 days ago
$SLS FREE MONEY. Anyone INVESTING NOW ahead of the 80th EVENT is GUARANTEED Profit.
SLS Announced the 60th Event, the share price Launched
SLS Announced the 72nd Event, the share price Launched
SLS Announced the 78th Event, the share price Launched
SLS is about to announce the 80th and Final Event ... Not the results just the 80th event, the share Price will launch ahead of the Phase 3 Result, which is about 40x more valuable than the current share price.
The 80th Event Puts $40B of Value on the Table.
- Ballistic Verticality incoming.
THE 80th EVENT PR is a A SURE THING WINNER - massive Catalyst to be Followed by an even more massive catalyst-Final Results Giving Gps the FDA Green Light to Generate Tens of Billions of Dollars
- Tens of Billions in Real Revenue worth $40B to $LLY $ABBV
- this $1.2B Manipulated Equity is worth $40B the Instant P3 Data Hits
$SLS Got to hand it to the Ceo, Really great set up here now, for Investors, with the imminent 80th.
- the share price will continue climbing, until it Launches.
Sure thing - investment opportunity of our lifetimes.
The Share Price Will be climbing a $40B Mountain of Value - until it Absolutely Launches when we get the 80th Event PR.
- as others have discussed, the 80th event may have already occurred just waiting for the data points to cycle through the process.
u/Run4theRoses2 — 7 days ago
78th Event PR - Phase 3 Results for a Revolutionary AML Remission Immunotherapy are Now Officially Imminent.
BE HOLDING and HOLD ON TIGHT.
$ABVX was a $5 Stock in the Days Leading up to its P3 Result it Doubled to $10 --- When the Result was Announced
- there was T1 TRADING HALT
- and GAP UP 600% to $60 In and Instant
-- and it Kept CLIMBING to a HIGH OF $148
... Something Very Similar is about to Happen Here - any day now.
u/Run4theRoses2 — 9 days ago
▲ 8 r/biotech_stocks
Rigged Market Offering the Investment Opportunity of a Lifetime. 40x 50x ROI Potential - SLS Phase 3 Results are Now Imminent - A revolutionary Immunotherapy for AML Remission Maintenance.
$6 Stock is about to be a $60 Stock and Climbing.
u/Run4theRoses2 — 9 days ago
Your Daily Reminder u/yG19 on ST / u/Commercial-ad9959 on REDDIT is actually paid to post here, and elsewhere by SHORT LONG Funds.
Your Daily Reminder u/yG19 is actually paid to post here, and elsewhere by SHORT LONG Funds.
the EVIDENCE is in the Fact - It Cannot - Deny it.
u/yG19 is Unable to Post the words " I AM NOT PAID TO POST "\
It is LYING ABOUT THE TIMELINE.
NOW YOU KNOW --- Ps Ask it ... see what happens.
PSSS ASK IT - and SEE WHAT HAPPENS...
Don't @ me ... ASK IT.... u/commercial-ad9959
even its name is admitting it, is a commercial ad.
u/Run4theRoses2 — 10 days ago
▲ 25 r/sellasLifescience
Share Price will Launch Just on the 80th Event PR.
Look at the Chart - when the 60th and the 72nd was announced.
Its Time to be Holding a Full Bag.
u/Run4theRoses2 — 12 days ago
▲ 30 r/sellasLifescience
Events are NOT Linear this far along in a OS trial for AML Cr2 Patients, who are Ineligible for Transplant - with inherent Co-Morbidities and the 26 month to 5+ year Time in Trial for those (at least 47) remaining alive, mean we could see A Rapid Spate of Events and Top Line Results ANY DAY NOW.
… its now May.
Given the Variable nature of events and the extended length of Survival for these TRANSPLANT INELIGIBLE Patients who Harbor Significant CoMorbidities remaining in trial, - there could easily be a rapid spate of successive events, at any time, and Institutional Funds, and all interested/invested parties must reconcile their positions with the Fact, we could see Final Topline Results any day now.
https://www.reddit.com/r/sellasLifescience/s/4WGeMcpt3b
Gps Phase 3 Registrational Results are coming - Giving Gps the FDA GREEN LIGHT to treat 100,000 AML Patients Currently in Remission and 50,000+ New Patients each Year
- a massive $28B TAM
- worth $40B to Big Pharma $180 per share, only a matter of time
- they are inevitable - it is inevitable that SLS Shares Will Be Launching -- we Are Officially in the ANY DAY NOW Zone -- A.D.N. Defined.
\- Events are NOT Linear this far along in a OS trial for AML Cr2 Patients,
- As of TODAY \*:
**at Least 47 REGAL Phase 3 Patients Remain Alive At Least 26 Months, ranging up to 62 Months.**
\- We have Enrollment Completion March/April 126/7 Patients
All Along the Time Points on the OS Plot curve - some patients remain alive at Least, 26 months - Some maybe 30 Months, 40 Months or 50...
Ranging UP To ... means there will be a # Patients in Trial 3 years 4 years and 5 ... and a great many may now be in Hospice, or well may have been after the Holidays - ANY DAY NOW is Not a Long Time to Wait for a Possible 47X ROI . . .
\- Note: Dec 26th CRO cutoff of 72 Events Did NOT Include Events from the Prior weeks, due to the Holidays
\- and the normal lag, from an event, patients families will need to inform the Dr. / Clinicians - takes some number of days/weeks, as families are not in a hurry/not a priority, dr's then will need to update the CRo - another number of days etc.
to be clear - the Dec 26th 72nd event PR DID NOT Include any events from the Prior 3 or 4 weeks, and no Post Holiday, Christmas/ New Year Events.
\- sad as it is, patients often hang on through the holidays, and let go after and during the Winter Terminus - AML Event Rates are Documentedly Higher during the Winter Months.
Investors must reconcile the Fact we could See 80 Events any day now \\\* Phase 3 Results are Imminently Due.
Bottom Line:
\* there were more than 72 Events in Dec.
--- July vs NOV 2023 - enrollment Lag
**Recall SLS expected 3D MED adding 25 -40 patients in Q2/ Q3/ Q4 2023 - Litigation Commenced in Dec 2023 along with Enrollment.**
\-- AND the Enrollment Back Loaded, MD Anderson Ucla Geffen, Baylor Med, Mayo Clinic sites, among others Discontinued Enrollment Mid/ 2023 - in July all these Sites had Closed Enrollment per there own websites, Given SLS was at 90-95 End of Q3 and Everyone Expected 3D MED to add 25-40 patients.
3DMED Litigation Initiated DEC 2023 - at Which TIME Enrollment Resumed and Completed in March - 22 Patients Added at the VERY End - who are ALL NOW in Trial at Least 22 months / there will be a Spate of Events From this Group / outside the normal event rate boundary.
**- We Should Expect to See the Phase 3 Top Line Results ANY DAY NOW - and Smart Money is**, **has been and will continue Moving Into Position.**
\- its going to be sooner than later to see 80.
\- Given all we know about BAT - there are 60 events +/- from control - in trial AT LEAST 26/27 months
126/7 Enrolled
\- 30 months - 105 enrolled Nov 2023
\- “you will not see survival past 12” Dr. Jamy.
then another 12 ish Events from GPs non Responders
72 Events accounted for.
\- Long Institutional Money is Feasting on every short sold shore, whether it's actual Short or Short Term Penny Flip Shares. At a certain point, the 'float' will be gone and SLS share prices will be climbing the Stairway to Heaven.
\* they're not ... you can find the details in prior posts.

u/Run4theRoses2 — 12 days ago
When - When is the $40B Question.
= ADN
SLS Market Cap is now up over 1,000% Since the IDMC Unblinded Actual Phase 3 MOS and IR data from the INTERIM ANALYSIS at 60 Events DEC 2024.
The unblinded data - Gave most HEME Industry Players a good sign Gps is Golden, now 6 months since the 72nd Event, and this far along - 25 months since enrollment completed, and median follow-up of 31 months (25-63) ALL Smart Investors must reconcile the fact the 80th event and instant share price launch could occur at any time.
Enrollment completed a solid 25 months ago - 13.5 months of Follow-Up at Interim, Now 31 months Follow-Up in a setting of "High Leukemic Risk" Dr. Kantarian Chair of MD Anderson's Leukemia Dept., REGAL Phase 3 Global Lead and Steering Committee Chair.
- AML CR2 Maintenance Transplant Ineligible Setting, where 3 Dr's treating actual patients are on record stating MOS for BAT is only 6-8 months, Aza/VEN BAT Failed 3 Recent P3 trials, including VIALE-M AML CR1 Remission Maintenance.
- Dr. Jamy - largest enrolling US clinicians, was asked what's the longest OS on BAT he sees in his practice. '6-8 Months MEDIAN', 'you will not see survival past 12 months', in any trial.
31 Month Median Follow up - Ranging to 63 months, Long Tail Survivors
are now exceeding OS for CR1 Transplant.
Every day - GPs Value Grows, as more investors / fund analysts, discover and become more convinced - It's Gps causing the Near Miraculous All Pooled Survival.
Unfortunately, we have to reconcile the Fact there could be a Rapid Spate of events and the 80th is announced.
*protip: Review SLS Share Price Since the Dec 2025 72 Event Announcement.
u/Run4theRoses2 — 16 days ago
▲ 38 r/sellasLifescience
$SLS $PFE $LLY $ABBV Smarter than you, know this Enhanced Dosing Discovery by Harvard Professor, Dr. Amrein Completely deRisks 009.
Dr. Amrein's data Confirms 009 Future Data - will Be Better - than Prior P2B SLS009 data published at ASH,
- which was better than data that got bought for $4.9B.
$SLS $0.888B 600% ROI on the Table - FREE MONEY
SLS009 P2B ORR of 57% for End Stage AML-MR END STAGE Patients will be IMPROVED in Front Line with Enhanced Dosing. It is Certain.
u/Run4theRoses2 — 29 days ago